Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Jul 2026 for Ovid Therapeutics Inc..
Filing timeline
BuySaleCharles Ross Carter
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Charles Ross Carter: trading record in brief
Filings by Charles Ross Carter span 2 companies, the busiest being Icad Inc and Ovid Therapeutics Inc. Over a trading history stretching from 8 December 2021 to 6 July 2026, the count stands at 2 filings.
Every open-market trade on record is a purchase: 1 purchase worth €44k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant.
On 8 July 2026 came the latest disclosure, a share grant in Ovid Therapeutics Inc. The last purchase on record was published on 15 December 2021, which is 1,774 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Charles Ross Carter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
50,000 shares0Common StockSEC:0001779359-26-000004:0
7,000 shares@ US$7.05100.0% of flowCommon StockSEC:0000899243-21-048350:0
Canonical exit: 8 Mar 2022 (T+90)
2 of 2 declarations
